A Study Assessing Efficacy and Safety of SAR125844 in NSCLC Patients With MET Amplification

Clinical trial NCT02435121 · COMPLETED

Trial details

NCT number: NCT02435121
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neoplasm Malignant

Start date: 2015-11-01
Primary completion: 2016-01-01
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.